Streeting’s resignation comes in the wake of the Labour party’s poor performance in the local elections, held on 7 May.
Hundreds of biopharma leaders say Dr Richard Pazdur has the necessary qualities to lead the FDA amid a crisis of confidence.
Following the update, healthcare providers can increase both the dose and frequency of Crysvita for XLH patients after treatment.
Key opinion leaders interviewed by GlobalData were near-unanimous in recognising tirzepatide as the current best-in-class obesity therapy.
The trial enrolled participants who had completed the SURMOUNT-5 study and achieved at least 5% weight loss.
The JV aims to scale the commercialisation of branded and specialised pharmaceutical products for the US market.
